In a sweeping new lawsuit, over 900 people are claiming that Ozempic and other GLP-1 drugs caused them long-term gastrointestinal damage. As the Pittsburgh Post-Gazette reports, this is the first lawsuit of its kind targeting GLP-1s, which is believed to mimic the stomach's feeling of fullness and carries laundry lists of both unrelated benefits and concerning side […]